Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAGRAXOFUSP-ERZS vs TALAZOPARIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TAGRAXOFUSP-ERZS vs TALAZOPARIB: Safety Overview

Metric TAGRAXOFUSP-ERZS TALAZOPARIB
Total FAERS Reports 438 1,477
Deaths Reported 114 278
Death Rate 26.0% 18.8%
Hospitalizations 116 553
Average Patient Age 65.9 yrs 60.1 yrs
% Female Patients 22.8% 55.7%
FDA Approval Date N/A Jun 20, 2023
Manufacturer N/A Pfizer Laboratories Div Pfizer Inc
Route N/A ORAL
Marketing Status Prescription Discontinued